HPV Test
High-risk Human Papillomavirus
Key Facts
Indication
High-risk Human Papillomavirus
Phase
Commercial/Development
Status
Active
Company
About Co-Diagnostics
Co-Diagnostics is a molecular diagnostics company focused on developing, manufacturing, and marketing tests based on its patented CoPrimer™ technology platform, which aims to improve PCR specificity and sensitivity. The company has commercialized tests for diseases including tuberculosis, hepatitis, HPV, malaria, and SARS-CoV-2, and operates a dual revenue model through direct product sales and IP licensing via its joint venture in India. Its strategy centers on expanding its infectious disease portfolio, growing its global distribution network, and leveraging its platform's flexibility for partnerships and new assay development.
View full company profile